Featured Research

from universities, journals, and other organizations

Doctors Use Novel Methods To More Effectively Treat Lung Cancer

Date:
October 26, 2000
Source:
Memorial Sloan-Kettering Cancer Center
Summary:
Doctors at Memorial Sloan-Kettering Cancer Center are developing new ways to more effectively treat lung cancer with radiation therapy by using enhanced imaging to better define tumors during treatment planning, and delivering higher doses with fewer side effects.

BOSTON, MA – Doctors at Memorial Sloan-Kettering Cancer Center are developing new ways to more effectively treat lung cancer with radiation therapy by using enhanced imaging to better define tumors during treatment planning, and delivering higher doses with fewer side effects. Center researchers will present preliminary findings on these promising techniques at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Boston this week.

Approximately 175,000 people will be diagnosed with lung cancer in the US this year. It is the most common cause of cancer-related death among both men and women, accounting for 28 percent of all cancer deaths in the country. Because of limitations in diagnostic testing, the disease is often discovered at a more advanced stage when it is more difficult to treat. Radiation therapy has been shown to be the most effective treatment option for patients in whom the cancer is inoperable – when it has spread beyond the lung but is confined to the chest.

One study being presented highlights the use of Positron Emission Tomography (PET), which is a more sensitive imaging technique than Computed Tomography (CT), to identify lesions, determine the extent and spread of the cancer, and detect the presence of early disease in the lymph nodes. Cancer causes changes and obstructions in the lung tissue that make it difficult to clearly see the tumor when planning radiation treatment. PET improves the accuracy of radiation therapy by better contrasting and delineating the lung tumors and normal tissue during the planning done prior to treatment.

Memorial Sloan-Kettering researchers will report that each of the ten patients evaluated in the study have had changes made to their treatment plan as a result of PET data – the area intended to receive radiation was increased in six patients and decreased in four patients. “Using this sophisticated approach to accurately distinguish between cancerous and healthy tissue leads to more targeted radiation treatment and a better treatment outcome,” says Yusuf Erdi, DSc, a nuclear physicist at Memorial Sloan-Kettering and lead author of the study.

Researchers will also report on a new technique to reduce toxicity at the highest levels of radiation therapy. Because pulmonary tumors move when patients breathe, doctors have previously had to treat a wider area to hit this “moving target” in order to ensure that the lung tumors receive the ideal dose of radiation, increasing the side effects of treatment. However, physicians at Memorial Sloan-Kettering have discovered a way to immobilize the lung tumors during radiation treatment using a method called the “deep inspiration breath hold,” which decreases lung density and has allowed doctors to more safely treat patients at higher doses than ever.

The approach is used when free breathing with three-dimensional conformal radiation therapy does not allow for safe treatment at a high dose. It requires the patient to hold his or her breath for 10 seconds at a time to make sure the lung tumor stays still during treatment. This is repeated five or six times during each treatment episode. The individual must be at exactly the same breath level for each treatment, which is measured with a device called a spirometer. The therapy is only administered when the patient can maintain the same breath level as the last treatment.

“The deep inspiration breath hold allows for more targeted and thus safer treatment for large lung tumors that would otherwise not be eligible for dose escalation,” said Ken Rosenzweig, MD, a radiation oncologist with expertise in the treatment of lung cancer and who developed the technique at Memorial Sloan-Kettering. “Our findings show that high-dose radiation treatment can effectively control the rate of tumor growth with little toxicity despite locally advanced disease in the majority of patients,” said Dr. Rosenzweig. To date, 20 patients have completed high dose radiation treatment using the breath hold technique with positive results.


Story Source:

The above story is based on materials provided by Memorial Sloan-Kettering Cancer Center. Note: Materials may be edited for content and length.


Cite This Page:

Memorial Sloan-Kettering Cancer Center. "Doctors Use Novel Methods To More Effectively Treat Lung Cancer." ScienceDaily. ScienceDaily, 26 October 2000. <www.sciencedaily.com/releases/2000/10/001026085306.htm>.
Memorial Sloan-Kettering Cancer Center. (2000, October 26). Doctors Use Novel Methods To More Effectively Treat Lung Cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/10/001026085306.htm
Memorial Sloan-Kettering Cancer Center. "Doctors Use Novel Methods To More Effectively Treat Lung Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/10/001026085306.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins